+ All Categories
Home > Documents > RADAR-base: Major Depressive Disorder and Epilepsy Case Studies · 2018-10-25 · the case for...

RADAR-base: Major Depressive Disorder and Epilepsy Case Studies · 2018-10-25 · the case for...

Date post: 25-May-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
1
www.radar-cns.org [email protected] This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein. This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking 2 (RADAR-CNS grant No 115902) www.imi.europa.eu Hourly heart rate (bpm) RADAR-base: Major Depressive Disorder and Epilepsy Case Studies Stewart C 1 , Rashid Z 1 , Ranjan Y 1 , Shaoxiong Sun 1 , Dobson R 12 , Folarin AA 12 , The RADAR-CNS Consortium 3 1 Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience, King’s College London, Box P092, De Crespigny Park, SE5 8AF, UK 2 Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London WC1E 6BT, UK. 3 The RADAR-CNS Consortium, http://www.radar-cns.org/partners Aim 1: Major depressive disorder An ambulatory study monitoring MDD patients is being conducted across three sites. The objective is to collect regular self reported symptoms and metrics, such as sleep and ambulatory behaviour. High resolution data is being collected over a period of up to two years for each participant. Features from the passive data will be used to predict the mood state of participants, using both the questionnaires collected through the aRMT application, and through less frequently collected email questionnaires. Background Emerging mobile health technology could provide opportunities for remote monitoring and interventions for people with mental health and neurological disorders. RADAR-base is a modern mHealth data collection platform built around Confluent and Apache Kafka. Here we report progress on studies into two brain disorders: major depressive disorder and epilepsy. Initial results show smartphones and wearable devices have potential to improve care for patients with depression and epilepsy. HOW IT WORKS RADAR-base is composed of back-end infrastructure and two Android mobile apps; aRMT for active monitoring of participants requiring conscious action (e.g. questionnaires, audio questions, timed tests), and pRMT, a native Android app for passive monitoring of participants via phone and wearable sensors. In addition, devices with data available from another cloud service through an API can be integrated, which is the case for Fitbits worn in the MDD study. The two studies, MDD and epilepsy, generate data with very different complexity, volume, frequency and duration, displaying the versatility of the RADAR-base platform. Remote data collection for up to concurrent 500 participants with major depression over the course of 2 years. In-Hospital high frequency data collection for Epilepsy seizure detection for a period of ~1 week per subject. RESULTS AND VISION The preliminary data from the MDD study shows a range of depressive symptoms, with a mean PHQ-8 score of 10.4 and standard deviation of 6.2 in the 76 PHQ-8 questionnaires so far recorded. Five participants have had a depressive episode, progressing from a PHQ- 8 score < 10, no depression, to a score >= 10, current depression, in the following questionnaires. Of those, one returned to a 'no depression' state after a week. There is, therefore, already a small amount of intra- individual variation recorded, although longitudinal effects should become clearer as the follow-up data collection period continues. A tonic EDA response during the post-ictal period has been noted, and often occurs within the RADAR-EPI dataset. An example is given in Figure 3 showing an Empatica E4 recording of acceleration and EDA over a night-time 5-hour period. The convulsive seizure at 05:05 is followed by a large increase in skin conductance, with a peak at 05:10. There are other tonic peaks in the EDA, but they do not coincide with a seizure-like accelerometer trace. Equally, there is not evidence accelerometer traces with repetitive or otherwise confusable characteristics in the inter-ictal period being succeeded by an EDA response. Although not totally consistent across all participants and all seizures, it is a general pattern that illustrates the potential to use multiple modalities for increased specificity. Fig. 1: RADAR-base Overview. We would like to acknowledge The Hyve (http://thehyve.nl ) and RADAR-CNS Consortium ( http://www.radar-cns.org/partners) for their support. Backend Infrastructure facilities were provided by King's College London's Rosalind private cloud. The Authors receive funding support from the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. Fig. 2: Patient activity measured with their phone accelerometer with corresponding PHQ-8 and RSES scores. Each row corresponds to a day. The questionnaire scores suggest the participant is not in a depressive mood and has a normal level of self-esteem. Fig. 4: Data stream from a patient wearing an Empatica E4 during a night. The patient had a focal motor seizure at 05:05 (BST), corresponding to a burst of movement in the accelerometer (top), and subsequently followed by a peak in EDA (bottom). Other movements and peaks in EDA during the interictal periods do not follow the same pattern. Fig. 3: Fitbit heart rate and sleep The shaded areas show fitbit-calculated sleep periods, while the plot shows the measured hourly heart rate with std dev. and range. Aim 2: Epilepsy An in-hospital study is being carried out at two epilepsy monitoring units, to compare wearable devices against the gold standard of clinician labelled events using video-EEG. The goal in this study is to develop and algorithm to detect or predict seizures, and to compare the capabilities of study devices for a follow-up ambulatory study. Fig. 5: Modalities around surrounding a seizure event. (bottom left) PPG’s frequency domain shows how movement (top left) artifacts can cause loss of heart rate information during seizures [highlighted red]. The time points that accelerometry (top right), in the order of seconds, and skin conductance (bottom right), over many minutes post-seizure, are useful is significantly different.
Transcript
Page 1: RADAR-base: Major Depressive Disorder and Epilepsy Case Studies · 2018-10-25 · the case for Fitbits worn in the MDD study. The two studies, MDD and epilepsy, generate data with

[email protected]

This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking 2 (RADAR-CNS grant No 115902) www.imi.europa.eu H

ou

rly

he

art

rate

(b

pm

)

RADAR-base: Major Depressive Disorder and Epilepsy Case Studies

Stewart C1, Rashid Z1, Ranjan Y1, Shaoxiong Sun1, Dobson R12, Folarin AA12, The RADAR-CNS Consortium3

1 Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience, King’s College London, Box P092,

De Crespigny Park, SE5 8AF, UK

2 Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London WC1E 6BT, UK.

3 The RADAR-CNS Consortium, http://www.radar-cns.org/partners

Aim 1: Major depressive disorderAn ambulatory study monitoring MDD patients is being conducted across three sites. The objective is to collect regular self reported symptoms and metrics, such as sleep and ambulatory behaviour. High resolution data is being collected over a period of up to two years for each participant.Features from the passive data will be used to predict the mood state of participants, using both the questionnaires collected through the aRMT application, and through less frequently collected email questionnaires.

BackgroundEmerging mobile health technology could provide opportunities for

remote monitoring and interventions for people with mental health

and neurological disorders. RADAR-base is a modern mHealth data

collection platform built around Confluent and Apache Kafka.

Here we report progress on studies into two brain disorders: major

depressive disorder and epilepsy. Initial results show smartphones

and wearable devices have potential to improve care for patients

with depression and epilepsy.

HOW IT WORKSRADAR-base is composed of back-end infrastructureand two Android mobile apps; aRMT for activemonitoring of participants requiring conscious action(e.g. questionnaires, audio questions, timed tests), andpRMT, a native Android app for passive monitoring ofparticipants via phone and wearable sensors. Inaddition, devices with data available from anothercloud service through an API can be integrated, which isthe case for Fitbits worn in the MDD study.

The two studies, MDD and epilepsy, generate data withvery different complexity, volume, frequency andduration, displaying the versatility of the RADAR-baseplatform.

● Remote data collection for up to concurrent 500 participants with major depression over the course of 2 years.

● In-Hospital high frequency data collection for Epilepsy seizure detection for a period of ~1 week per subject.

RESULTS AND VISION

The preliminary data from the MDD study shows a range of depressive symptoms, with a mean PHQ-8 score of 10.4 and standard deviation of 6.2 in the 76 PHQ-8 questionnaires so far recorded. Five participants have had a depressive episode, progressing from a PHQ-8 score < 10, no depression, to a score >= 10, current depression, in the following questionnaires. Of those, one returned to a 'no depression' state after a week. There is, therefore, already a small amount of intra-individual variation recorded, although longitudinal effects should become clearer as the follow-up data collection period continues.

A tonic EDA response during the post-ictal period has been noted, and often occurs within the RADAR-EPI dataset. An example is given in Figure 3 showing an Empatica E4 recording of acceleration and EDA over a night-time 5-hour period. The convulsive seizure at 05:05 is followed by a large increase in skin conductance, with a peak at 05:10. There are other tonic peaks in the EDA, but they do not coincide with a seizure-like accelerometer trace. Equally, there is not evidence accelerometer traces with repetitive or otherwise confusable characteristics in the inter-ictal period being succeeded by an EDA response. Although not totally consistent across all participants and all seizures, it is a general pattern that illustrates the potential to use multiple modalities for increased specificity.

Fig. 1: RADAR-base Overview.

We would like to acknowledge The Hyve (http://thehyve.nl) and RADAR-CNS Consortium (http://www.radar-cns.org/partners) for their support. Backend Infrastructure facilities were provided by King's College London's Rosalind private cloud. The Authors receive funding support from the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.

Fig. 2: Patient activity measured with their phone accelerometer with corresponding PHQ-8 and RSES scores. Each row corresponds to a day. The questionnaire scores suggest the participant is not in a depressive

mood and has a normal level of self-esteem.

Fig. 4: Data stream from a patient wearing an Empatica E4 during a night. The patient had a focal motor seizure at 05:05 (BST), corresponding to a

burst of movement in the accelerometer (top), and subsequently followed by a peak in EDA (bottom). Other movements and peaks in EDA during the

interictal periods do not follow the same pattern.

Fig. 3: Fitbit heart rate and sleepThe shaded areas show fitbit-calculated sleep periods, while the plot shows

the measured hourly heart rate with std dev. and range.

Aim 2: EpilepsyAn in-hospital study is being carried out at two epilepsy monitoring units, to compare wearable devices against the gold standard of clinician labelled events using video-EEG.The goal in this study is to develop and algorithm to detect or predict seizures, and to compare the capabilities of study devices for a follow-up ambulatory study.

Fig. 5: Modalities around surrounding a seizure event.(bottom left) PPG’s frequency domain shows how movement (top left)

artifacts can cause loss of heart rate information during seizures [highlighted red]. The time points that accelerometry (top right), in the

order of seconds, and skin conductance (bottom right), over many minutes post-seizure, are useful is significantly different.

Recommended